Structured evidence table for Carnitine-Fatigue-Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Carnitine-Fatigue-Meta-Analysis | Mounting evidence highlights relevant metabolic dysregulation in PCS, with enduring disruptions in energy metabolism, amino acid metabolism, and lipid metabolism persisting for up to two years post-infection. | 4 | Oestreich Martin (2026) | Endothelial dysfunction and metabolic biomarkers in post-COVID-19 syndrome |
| Carnitine-Fatigue-Meta-Analysis | The aim of the current study was to compare soluble blood biomarkers of ED and amino acid, fatty acid, carnitine, eicosanoid and resolvin related metabolism in a well-characterized cohort of individuals with or without PCS at a median of 37.4 weeks post-acute infection and to investigate whether these biomarkers are associated with PCS-related fatigue severity. | 4 | Oestreich Martin (2026) | Endothelial dysfunction and metabolic biomarkers in post-COVID-19 syndrome |
| Carnitine-Fatigue-Meta-Analysis | The questionnaire includes five subscales: general fatigue, physical fatigue, reduced activity, reduced motivation and mental fatigue. | 4 | Oestreich Martin (2026) | Endothelial dysfunction and metabolic biomarkers in post-COVID-19 syndrome |
| Carnitine-Fatigue-Meta-Analysis | 1 According to the World Health Organization (WHO), the post-COVID-19 syndrome (PCS) is a condition characterized by symptoms that persist for at least three months following infection with SARS-CoV-2, last for more than two additional months, and cannot be attributed to any other underlying disease. | 4 | Oestreich Martin (2026) | Endothelial dysfunction and metabolic biomarkers in post-COVID-19 syndrome |
Source documents